THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA

THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA

.

Saved in:

Bibliographic Details
Main Author:	article Editorial
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2023-12-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/2390
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01)

Rare Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Posttransplant Thrombotic Microangiopathy
by: Akila Viswanathan, et al.
Published: (2024-12-01)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01)

Challenges in diagnosing thrombotic thrombocytopenic purpura
by: Jeremy W. Jacobs, et al.
Published: (2025-07-01)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
by: Umer Syed, et al.
Published: (2018-01-01)

Thrombotic Thrombocytopenic Purpura in Pediatric Patients
by: Niki Shrestha, et al.
Published: (2025-04-01)

Thrombotic Thrombocytopenic Purpura in Dengue Fever
by: Tze Yuan Tee, et al.
Published: (2021-07-01)

Campylobacter Jejuni and Thrombotic Thrombocytopenic Purpura
by: Roman Jaeschke, et al.
Published: (1990-01-01)

The FDA has approved the first medical drug for the treatment of primary immunodeficiency APDS
by: article Editorial
Published: (2023-05-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child
by: aida borgi
Published: (2013-06-01)

Treatment of 36 cases of thrombotic thrombocytopenic purpura
by: Suvajdžić-Vuković Nada D., et al.
Published: (2004-01-01)

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)
by: Jeanelle King, et al.
Published: (2017-11-01)

Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors
by: Alexey Youssef, et al.
Published: (2018-01-01)

Moxifloxacin (Avelox) Induced Thrombotic Thrombocytopenic Purpura
by: Sikander P. Surana, et al.
Published: (2012-01-01)

Nystagmus as the presenting sign of thrombotic thrombocytopenic purpura
by: Iatissam El Belhadji, et al.
Published: (2025-06-01)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023-12-01)

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024-07-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024-05-01)

The FDA has approved a new drug for the treatment of leukemia
by: article editorial
Published: (2024-12-01)

Recurrent Cryptogenic Stroke in a Young Woman: Congenital Thrombotic Thrombocytopenic Purpura Unmasked
by: Christopher Wanjiku, et al.
Published: (2022-12-01)

Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura
by: Éloïse Colliou, et al.
Published: (2025-01-01)

THE FDA HAS APPROVED THE FIRST DRUG FOR PEOPLE WITH PRADER – WILLI SYNDROME IN MEMORY OF A COLLEAGUE
by: article Editorial
Published: (2025-05-01)

Retained intrauterine device as cause of thrombotic thrombocytopenic purpura
by: Mateusz Klimek, et al.
Published: (2025-07-01)

Thrombotic Thrombocytopenic Purpura in Oman: Disease Burden and Outcomes
by: Samata Al Dowaiki, et al.
Published: (2024-11-01)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024-07-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-05-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)

FDA Has Approved First Long-Acting Growth Hormone Preparation for Children
by: article Editorial
Published: (2021-12-01)

Thrombotic Thrombocytopenic Purpura Associated with the Acquired Immune Deficiency Syndrome
by: Anand Kumar, et al.
Published: (1992-01-01)

A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA RELATED TO MALIGNITY AND CHEMOTHERAPY
by: Ebru Kavak Yavuz, et al.
Published: (2024-12-01)

Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)
by: Mihaela-Sabrina HERDEA, et al.
Published: (2025-03-01)

Management of refractory thrombotic thrombocytopenic purpura: a case report
by: Yang ZHANG, et al.
Published: (2023-06-01)

Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia
by: Ramesh Kumar Pandey, et al.
Published: (2017-01-01)

FOR THE FIRST TIME, THE FDA HAS APPROVED A GEL FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM AT HOME
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C
by: Article Editorial
Published: (2024-11-01)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023-08-01)

The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus
by: Hang Ma, et al.
Published: (2025-04-01)

Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Michael R. Snyder, et al.
Published: (2025-03-01)